|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.0706 EUR | -3.95% |
|
+2.32% | +8.28% |
| Jan. 05 | TME Pharma N.V. Provides Update on Its Activities | CI |
| Nov. 17 | TME Pharma N.V. Announces Extension of Certain Bond Agreements | CI |
Sales 2024 by Business Segment
Sales 2024 by Geography
Historical Breakdown of Revenue by Business Segments
Net Income: Breakdown by Business Segment
| Fiscal Period: December | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
Drug Delivery Technologies | ||||||||||
Pharmaceuticals | 35K | 33K | - | - | 19K | |||||
Total Assets | 10.65M | 9.77M | 5.24M | 2.49M | 3.41M | |||||
Interest Expense | -3K | -49K | -133K | -17K | -18K | |||||
Income Tax Expense | - | 1K | 7K | 2K | - | |||||
CAPEX | -39K | -14K | -21K | -19K | -16K | |||||
EBT | -10.41M | -14.45M | -15.13M | -6.73M | -5.72M | |||||
D&A | 63K | 66K | 92K | 144K | 78K | |||||
Operating Income | -5.77M | -13.27M | -12.03M | -5.62M | 5.25M | |||||
Net Income | -10.4M | -14.45M | -15.13M | -6.74M | -5.72M |
Geographical Revenue Distribution History
| Fiscal Period: December | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
Germany | 35K | 33K | - | - | 19K | |||||
Total Assets | 10.65M | 9.77M | 5.24M | 2.49M | 3.41M | |||||
Interest Expense | -3K | -49K | -133K | -17K | -18K | |||||
Income Tax Expense | - | 1K | 7K | 2K | - | |||||
D&A | 63K | 66K | 92K | 144K | 78K | |||||
CAPEX | -39K | -14K | -21K | -19K | -16K | |||||
Net Income | -10.4M | -14.45M | -15.13M | -6.74M | -5.72M | |||||
EBT | -10.41M | -14.45M | -15.13M | -6.73M | -5.72M | |||||
Operating Income | -5.77M | -13.27M | -12.03M | -5.62M | 5.25M |
- Stock Market
- Equities
- ALTME Stock
- Financials TME Pharma N.V.
- Business Segments
Select your edition
All financial news and data tailored to specific country editions
